Sukun Kim, Ph.D. - Related publications

2007 University of California, Berkeley, Berkeley, CA 
Computer Architecture & Engineering (ARC); Energy (ENE); Operating Systems & Networking (OSNT); Programming Systems (PS); Security (SEC); Parallel architecture; High-performance networks; Workstation clusters
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Choueiri TK, Atkins MB, Rose TL, Alter RS, Ju Y, Niland K, Wang Y, Arbeit R, Parasuraman S, Gan L, McDermott DF. A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy. Investigational New Drugs. PMID 33507454 DOI: 10.1007/s10637-020-01058-2   
2021 Wang K, Wang H, Lv Y, Liu H, Liu J, Zhang Y. Camrelizumab combined with lenvatinib in the treatment of gastric cancer with liver metastasis: a case report. Annals of Palliative Medicine. 10: 803-809. PMID 33545802 DOI: 10.21037/apm-20-2572   
2021 Romani C, Salviato E, Paderno A, Zanotti L, Ravaggi A, Deganello A, Berretti G, Gualtieri T, Marchini S, D'Incalci M, Mattavelli D, Piazza C, Bossi P, Romualdi C, Nicolai P, et al. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Theranostics. 11: 2987-2999. PMID 33456584 DOI: 10.7150/thno.45157   
2021 How JA, Jazaeri A, Westin SN, Sood AK, Ramondetta LM, Xu M, Abonofal A, Karp DD, Subbiah V, Stephen B, Rodon JA, Yang F, Naing A. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Investigational New Drugs. PMID 33415580 DOI: 10.1007/s10637-020-01043-9   
2021 Okabe N, Mine H, Takagi H, Watanabe M, Muto S, Matsumura Y, Shio Y, Suzuki H. Pulmonary large cell carcinoma, highly positive for PD-L1, shows marked response to pembrolizumab: A case report. Thoracic Cancer. PMID 33605014 DOI: 10.1111/1759-7714.13850   
2021 Yue D, Qian J, Chen Z, Zhang B, Chen P, Zhang L, Li J, Zhang H, Wang C. Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with -rearranged lung adenocarcinoma. Journal For Immunotherapy of Cancer. 9. PMID 33558279 DOI: 10.1136/jitc-2020-001967   
2021 Tajima H, Makino I, Gabata R, Okazaki M, Ohbatake Y, Shimbashi H, Nakanuma S, Saitoh H, Shimada M, Yamaguchi T, Okamoto K, Moriyama H, Kinoshita J, Nakamura K, Miyashita T, et al. A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus -paclitaxel for resectable pancreatic cancer. Molecular and Clinical Oncology. 14: 26. PMID 33414907 DOI: 10.3892/mco.2020.2188   
2021 Chu QS, Bouganim N, Fortier C, Zaknoen S, Stille JR, Kremer JD, Yuen E, Hui YH, de la Peña A, Lithio A, Smith PS, Batist G. Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors. Investigational New Drugs. PMID 33479856 DOI: 10.1007/s10637-020-01049-3   
2021 Hasan MJ, Rabbani R, Anam AM, Huq SMR. Additional baricitinib loading dose improves clinical outcome in COVID-19. Open Medicine (Warsaw, Poland). 16: 41-46. PMID 33364433 DOI: 10.1515/med-2021-0010   
2021 Karlsson MJ, Costa Svedman F, Tebani A, Kotol D, Höiom V, Fagerberg L, Edfors F, Uhlén M, Egyhazi Brage S, Maddalo G. Inflammation and apolipoproteins are potential biomarkers for stratification of cutaneous melanoma patients for immunotherapy and targeted therapy. Cancer Research. PMID 33574091 DOI: 10.1158/0008-5472.CAN-20-2000   
2021 Montrone M, Longo V, Catino A, Pizzutilo P, Galetta D. [Efficacy of pralsetinib in a patient with advanced lung adenocarcinoma positive for RET rearrangement: the importance of Comprehensive Genomic Profiling.] Recenti Progressi in Medicina. 112: 10e-13e. PMID 33512367 DOI: 10.1701/3525.35132   
2021 Alkassis S, Alshare B, Ahmed S. Maintained Complete Response and Long-Term Survival in Epidermal Growth Factor Receptor Mutated Metastatic Non-Small Cell Lung Cancer with Erlotinib. Cureus. 13: e12451. PMID 33552769 DOI: 10.7759/cureus.12451   
2021 Naidus E, Bouquet J, Oh DY, Looney TJ, Yang H, Fong L, Standifer NE, Zhang L. Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients. Cancer Immunology, Immunotherapy : Cii. PMID 33420629 DOI: 10.1007/s00262-020-02833-z   
2021 Iwasaki H, Toda S, Murayama D, Kato S, Matsui A. Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach. Molecular and Clinical Oncology. 14: 32. PMID 33414913 DOI: 10.3892/mco.2020.2194   
2021 Chen S, Sun J, Zhao L, Sun Y, Jia D, Song Y, Luo J, Lei H, Liu N. Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment. Experimental and Therapeutic Medicine. 21: 62. PMID 33365062 DOI: 10.3892/etm.2020.9494   
2021 Edwards BD, Edwards J, Cooper R, Kunimoto D, Somayaji R, Fisher D. Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting. Plos One. 16: e0246993. PMID 33592031 DOI: 10.1371/journal.pone.0246993   
2021 Matsuda A, Yamada T, Matsumoto S, Shinji S, Ohta R, Sonoda H, Takahashi G, Iwai T, Takeda K, Sekiguchi K, Yoshida H. Systemic Chemotherapy is a Promising Treatment Option for Patients with Colonic Stents: A Review. Journal of the Anus, Rectum and Colon. 5: 1-10. PMID 33537495 DOI: 10.23922/jarc.2020-061   
2021 Avaliani T, Sereda Y, Davtyan H, Tukvadze N, Togonidze T, Kiria N, Denisiuk O, Gozalov O, Ahmedov S, Hovhannesyan A. Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020. Monaldi Archives For Chest Disease = Archivio Monaldi Per Le Malattie Del Torace. 91. PMID 33470088 DOI: 10.4081/monaldi.2021.1679   
2021 Long ZY, Lu Y, Li M, Chen G, Shi L, Xiao X, Bai Y, Zhang HM, Wang Z. Effective treatment of anlotinib in giant delayed pulmonary metastasis of osteosarcoma: a case report and literature review. Annals of Palliative Medicine. PMID 33548989 DOI: 10.21037/apm-20-1790   
2021 Chen S, Lin W, Wen J, Xie B, Chen L, Chen G. Is glucagon-like peptide 1 receptor analogues effective and safe in severe COVID-19 patients with type 2 diabetes?-a case report. Annals of Palliative Medicine. PMID 33440950 DOI: 10.21037/apm-20-1982   
2021 Sapienza LG, Nasra K, Berry R, Danesh L, Little T, Abu-Isa E. Clinical effects of morning and afternoon radiotherapy on high-grade gliomas. Chronobiology International. 1-10. PMID 33557650 DOI: 10.1080/07420528.2021.1880426   
2021 Sarhan RM, Madney YM, Abou Warda AE, Boshra MS. Therapeutic efficacy, mechanical ventilation, length of hospital stay, and mortality rate in severe COVID-19 patients treated with tocilizumab. International Journal of Clinical Practice. e14079. PMID 33550688 DOI: 10.1111/ijcp.14079   
2021 Sheng J, Zhang J, Baudelet C, Roy A. Clinical Benefit-Risk Assessment of Nivolumab 240 mg Q2W in Chinese Patients With Advanced and Metastatic Solid Tumors. Journal of Clinical Pharmacology. PMID 33501654 DOI: 10.1002/jcph.1821   
2021 Nassif EF, Mlecnik B, Thibault C, Auvray M, Bruni D, Colau A, Compérat E, Bindea G, Catteau A, Fugon A, Boquet I, Martel M, Camparo P, Colin P, Zakopoulou R, et al. The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival. Cancers. 13. PMID 33525361 DOI: 10.3390/cancers13030494   
2021 Roboz GJ, Desai P, Lee S, Ritchie EK, Winer ES, DeMario M, Brennan B, Nüesch E, Chesne E, Brennan L, Lechner K, Kornacker M, DeAngelo DJ. A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia & Lymphoma. 1-13. PMID 33586590 DOI: 10.1080/10428194.2021.1881509   
2021 Jacob A, Shook J, Hutson T. The implementation of lenvatinib/everolimus or lenvatinib/pembrolizumab combinations in the treatment of metastatic renal cell carcinoma. Expert Review of Anticancer Therapy. 1-8. PMID 33393393 DOI: 10.1080/14737140.2021.1868994   
2021 Body A, Prenen H, Lam M, Davies A, Tipping-Smith S, Lum C, Liow E, Segelov E. Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges. Clinical Colorectal Cancer. PMID 33531256 DOI: 10.1016/j.clcc.2020.12.005   
2021 Isoda K, Nakade J, Suga Y, Fujita A, Shimada T, Sai Y. Initial Serum C-reactive Protein Level as a Predictor of Increasing Serum Vancomycin Concentration During Treatment. Therapeutic Drug Monitoring. PMID 33538550 DOI: 10.1097/FTD.0000000000000870   
2021 Fan L, Liu H, Li N, Liu C, Gu Y, Liu Y, Chen Y. Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: A single-center, retrospective, observational study. Medicine. 100: e23923. PMID 33466134 DOI: 10.1097/MD.0000000000023923   
2021 Furihata K, Ishiguro Y, Yoshimura N, Ito H, Katsushima S, Kaneko E, Shimabe M, Mukai M, Watanabe R, Morishige T. A Phase 1 Study of KHK4083: A Single-Blind, Randomized, Placebo-Controlled Single-Ascending-Dose Study in Healthy Adults and an Open-Label Multiple-Dose Study in Patients With Ulcerative Colitis. Clinical Pharmacology in Drug Development. PMID 33512065 DOI: 10.1002/cpdd.918   
2021 Cruz LR, Baladrón I, Rittoles A, Díaz PA, Valenzuela C, Santana R, Vázquez MM, García A, Chacón D, Thompson D, Perera G, González A, Reyes R, Torres L, Pérez J, ... , et al. Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial. Acs Pharmacology & Translational Science. 4: 206-212. PMID 33615173 DOI: 10.1021/acsptsci.0c00175   
2021 Kemp Bohan PM, Chick RC, O'Shea AE, Vreeland TJ, Hickerson AT, Cindass JL, Ensley DC, Hale D, Clifton GT, Sohn VY, Thompson IM, Peoples GE, Liss MA. Phase I Trial of Encapsulated Rapamycin in Prostate Cancer Patients Under Active Surveillance to Prevent Progression. Cancer Prevention Research (Philadelphia, Pa.). PMID 33514567 DOI: 10.1158/1940-6207.CAPR-20-0383   
2021 Salgado Filho N, Lages JS, Brito DJA, Santos EJF, Dos Santos AM, de Souza FL, Mendes VGG, Silva GADS, Carneiro ECRL, Muniz MPR, Silva GEB, Sesso RCC. Variability in Hemoglobin Levels and the Factors Associated with Mortality in Hemodialysis Patients: A 78-Month Follow-Up Study. International Journal of Environmental Research and Public Health. 18. PMID 33530448 DOI: 10.3390/ijerph18031078   
2021 Yin MP, Xie PF, Zhao Y, He W, Ma YZ, Li CX, Li Z, Zeng YW, Wu G. Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer. Journal of Cancer. 12: 1493-1498. PMID 33531994 DOI: 10.7150/jca.46877   
2021 Kato T, Matsuhashi N, Tomita H, Takahashi T, Iwata Y, Fukada M, Yasufuku I, Suetsugu T, Imai T, Mori R, Imai H, Tanaka Y, Okumura N, Hara A, Yoshida K. MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer. In Vivo (Athens, Greece). 35: 203-213. PMID 33402467 DOI: 10.21873/invivo.12249   
2021 Cohen YC, Zada M, Wang SY, Bornstein C, David E, Moshe A, Li B, Shlomi-Loubaton S, Gatt ME, Gur C, Lavi N, Ganzel C, Luttwak E, Chubar E, Rouvio O, et al. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nature Medicine. PMID 33619369 DOI: 10.1038/s41591-021-01232-w   
2021 Bhuiyan AS, Bari MA, Aditya G, Chowdhury UW, Wahab MA, Rahman MM, Islam MS, Rahman MM, Sharker MA, Rahman MS, Hossain M. Prevalence and Pattern of Dyslipidemia in Diabetes Mellitus Patients Admitted in the Department of Cardiology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh. Mymensingh Medical Journal : Mmj. 30: 21-27. PMID 33397846   
2021 Zhang F, Gao F, Wang K, Liu X, Zhang Z. MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway. Stem Cell Research & Therapy. 12: 115. PMID 33546760 DOI: 10.1186/s13287-021-02183-2   
2021 Xu Z, Zhang Y, Yu YH. Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report. Annals of Palliative Medicine. 10: 785-792. PMID 33545800 DOI: 10.21037/apm-20-2275   
2021 Sugawara R, Sugiyama H, Nakamura K, Tohgi K, Hongo T, Tsuchiya M, Momoki N, Nose S, Yutani C, Ikeda Y, Ikeda T, Ito H. Electron Microscopy Revealed Massive Lipid Droplets in Cardiomyocytes in a Patient with Cardiogenic Shock Following a Fulminant Type 1 Diabetes Mellitus. International Heart Journal. 62: 197-200. PMID 33518659 DOI: 10.1536/ihj.20-537   
2021 Lipovy B, Holoubek J, Hanslianova M, Cvanova M, Klein L, Grossova I, Zajicek R, Bukovcan P, Koller J, Baran M, Lengyel P, Eimer L, Jandova M, Kostal M, Brychta P, et al. Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications. Microorganisms. 9. PMID 33477980 DOI: 10.3390/microorganisms9010202   
2021 Giavedoni P, Martinez C, Podlipnik S, Suárez-Lleidó M, Martí-Martí I, Morgado-Carrasco D, Rovira M, Fernández-Avilés F, Gutiérrez G, Rosiñol L, Cid J, Lozano M, Mascaró JM. Assessment of Sclerodermoid Chronic Graft-versus-host Disease with Colour Doppler Ultrasound. Acta Dermato-Venereologica. PMID 33475145 DOI: 10.2340/00015555-3747   
2021 Santos M, Monteiro E. Time between Diagnosis and Treatment of Hypopharynx and Larynx Cancer: Are Longer Delays Associated with Higher Discrepancy between Clinical and Pathological Staging? International Archives of Otorhinolaryngology. 25: e108-e114. PMID 33542760 DOI: 10.1055/s-0040-1708898   
2021 Wang H, Hu L, Bai GQ, Liu Z, Yu GG, Wang W, Sun L. [Serum C-reactive protein, cholinesterase and prealbumin are correlated with prognosis of severe coronavirus disease 2019 patients]. Zhonghua Nei Ke Za Zhi. 60: 134-138. PMID 33503724 DOI: 10.3760/cma.j.cn112138-20200421-00404   
2021 Deng J, Chen W, Wu X, Zhou Y, Li J. Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma. Medicine. 100: e24060. PMID 33429769 DOI: 10.1097/MD.0000000000024060   
2021 van Ewijk R, Vaarwerk B, Breunis WB, Schoot RA, Ter Horst SAJ, van Rijn RR, van der Lee JH, Merks JHM. The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma. Cancers. 13. PMID 33561094 DOI: 10.3390/cancers13030510   
2021 Akizawa T, Nobori K, Matsuda Y, Hayashi Y, Hayasaki T, Yamamoto H. Molidustat for anemia correction in Japanese patients undergoing hemodialysis: a single-arm, phase 3 study. Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society For Apheresis, the Japanese Society For Apheresis, the Japanese Society For Dialysis Therapy. PMID 33506635 DOI: 10.1111/1744-9987.13627   
2021 Yu Y, Wang Y, Wu L, Xu X, Zhou H, Wang Q, Zhou J. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study. Medicine. 100: e23712. PMID 33592829 DOI: 10.1097/MD.0000000000023712   
2021 An YW, Song S, Li WX, Chen YX, Hu XP, Zhao J, Li ZW, Jiang GY, Wang C, Wang JC, Yuan B, Liu HQ. Liver function recovery of COVID-19 patients after discharge, a follow-up study. International Journal of Medical Sciences. 18: 176-186. PMID 33390786 DOI: 10.7150/ijms.50691   
2021 Balzarotti M, Magagnoli M, Canales MÁ, Corradini P, Grande C, Sancho JM, Zaja F, Quinson AM, Belsack V, Maier D, Carlo-Stella C. A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma. Investigational New Drugs. PMID 33523334 DOI: 10.1007/s10637-020-01054-6